SUBSCRIBE
SUBSCRIBE

FDA

Business
The Day In Review: Nuvelo, Inc. Expands Archemix Corporation Deal
August 1, 2006
 · 
1 min read
FDA
FDA OKs Pearly Pigments To Color Pills
July 21, 2006
 · 
1 min read
FDA
Snail Venom Painkiller Launched
July 10, 2006
 · 
1 min read
FDA
ImClone Systems And ImClone Systems Release: FDA Approves ERBITUX(R) For Treatment Of Head And Neck Cancer; First And Only Approved Monoclonal Antibody For Squamous Cell Carcinoma Of The Head And Neck
March 1, 2006
 · 
1 min read
FDA
FDA Approves Health Claim For Barley
December 28, 2005
 · 
3 min read
FDA
Lyrica Relieves Diabetes Pain
October 19, 2005
 · 
1 min read
FDA
Onyx’s Setback. Why We Still Like The Stock
October 19, 2005
 · 
1 min read
FDA
Amgen Gets EU Approval For Mimpara
October 19, 2005
 · 
1 min read
FDA
Johnson & Johnson Gains On FDA Approval Of Disk
October 19, 2005
 · 
1 min read
FDA
Biotech Investors: Mark Your 2005 Calendars
October 19, 2005
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease
May 8, 2026
 · 
18 min read
Press Releases
InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren’s Syndrome in China
May 8, 2026
 · 
3 min read
Press Releases
Owlet Announces First Quarter 2026 Financial Results; Updates 2026 Guidance
May 8, 2026
 · 
17 min read
Press Releases
Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
May 8, 2026
 · 
15 min read
Press Releases
Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract
May 8, 2026
 · 
3 min read
Press Releases
RIVANNA receives FDA 510(k) clearance for Accuro XV musculoskeletal ultrasound imaging system
May 8, 2026
 · 
4 min read
Press Releases
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
May 7, 2026
 · 
4 min read
Press Releases
Bright Uro Receives FDA Clearance For Glean® Abdominal Sensor
May 7, 2026
 · 
4 min read
Press Releases
Mezzion Reports Pre-IND FDA Feedback on the Development of Udenafil in ADPKD
May 7, 2026
 · 
2 min read
Press Releases
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
May 7, 2026
 · 
8 min read
Press Releases
Repertoire Immune Medicines Announces FDA Fast Track Designation for its Investigational Immune Medicine, RPTR-1-201
May 7, 2026
 · 
3 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Regulatory Update Following Type A Meeting with U.S. Food and Drug Administration (FDA) on Tabelecleucel Biologic License Application (BLA)
May 7, 2026
 · 
3 min read
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality
May 7, 2026
 · 
5 min read
Press Releases
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
May 7, 2026
 · 
4 min read
Press Releases
Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline
May 7, 2026
 · 
11 min read
Press Releases
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
May 7, 2026
 · 
11 min read
Press Releases
InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China
May 7, 2026
 · 
3 min read
Press Releases
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
May 7, 2026
 · 
15 min read
Press Releases
FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
May 7, 2026
 · 
2 min read
Press Releases
FDA Expands AI Capabilities and Completes Data Platform Consolidation
May 7, 2026
 · 
2 min read
Load More